Tag Archive for: FDA

Coronavirus feat

Coronavirus and Cancer Resources for Survivors

Cancer survivors have expressed concerns and questions about COVID-19, the coronavirus, and how they may be at higher risk due to their cancer history. Here are some resources about COVID-19 generally, and its impact for cancer survivors specifically. NCCS is seeking answers from public health experts on the coronavirus and its impact on cancer patients and survivors. Please leave a comment [...]
NCCS Starburst 250px

WCOE: Countering HHS’s ACA Enrollment Suppression, FDA’s Gottlieb on Expanded Access/Right to Try, “Cancer Stories No One Wants to Hear”

What Caught Our Eye (WCOE) is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. — “As ACA enrollment nears, administration keeps cutting federal support of the law” – By Juliet Eilperin, Washington Post — With the fifth enrollment season set to begin Nov. 1, advocates say the Health and Human Services Department has done more to suppress the number of people [...]
NCCS Starburst 250px

What Caught Our Eye: Cassidy-Graham Repeal Bill Analysis; Bipartisan Talks; Improving End-of-Life Care; Biosimilars in Cancer; and More

What Caught Our Eye (WCOE), September 15, 2017 - “New Graham-Cassidy Bill: A Last GOP Shot At ACA Repeal And Replace Through Reconciliation” - By Timothy Jost, Health Affairs — The fundamental idea of the Graham-Cassidy bill is to terminate the ACA’s Medicaid expansions, premium tax credits, cost-sharing reduction payments, small business tax credits, and Basic Health Program as of 2019 and redistribute the money [...]
NCCS Starburst 250px

What Caught Our Eye 8/4: GOP Governors Look to Cut Medicaid, Young Cancer Survivors Struggle Socially, Right to Try, FDA Funding, & More

What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. “Republicans in Congress Bypass Trump to Shore Up Health Law” - Via New York Times — Congressional Republicans moved on Tuesday to defuse President Trump’s threat to cut off critical payments to health insurance companies, maneuvering around the president toward bipartisan legislation [...]
NCCS Starburst 250px

What Caught Our Eye: Advocates Raise Their Voices Over ACA Repeal; CDC Finds Disparity in Rural Cancer Deaths; Genetic Privacy; and More

What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. In the Spotlight: “Local cancer survivor continues to fight, this time for health care" – From KRIS-TV – “I’m not just up there on Capitol Hill for myself, but I’m taking the concerns of our constituents here at home to Capitol Hill as well.” [...]
NCCS Starburst 250px

What Caught Our Eye: ‘Extremely High Premiums’ for the Sick, AHCA News, FDA Aims to Control Rx Pricing, & More

What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. Via Kaiser Health News — "The Republican overhaul of the federal health law passed by the House this month would result in slightly lower premiums and slightly fewer uninsured [...]
NCCS Starburst 250px

What Caught Our Eye: A New GOP Health Plan, Looming Uncertainty for Insurers, Sharing Genetic Cancer Risks with Children, and More

Trumpcare is back. And worse than ever. — Via Vox.com — “House Republicans are floating a new amendment to their health care bill — one that would likely cause even more Americans to lose coverage than the last version. Leaders of the staunchly conservative Freedom Caucus and the more moderate Tuesday Group have reportedly hashed out a proposal that would let some states ditch key Obamacare policies, such as the [...]
NCCS Starburst 250px

What Caught Our Eye: Next Steps for the ACA; Gottlieb’s Confirmation; ASCO Statement on Right-to-Try; Gene Mutations in Childhood Survivors

Some key findings of the most recent Kaiser tracking poll: the public thinks it’s a “good thing” that the AHCA failed, believes President Trump and the Republican party are responsible for problems with the ACA going forward, and want to see the Trump administration make the ACA work for consumers. “Despite divided views towards the 2010 health law, three-fourths of the public think President Trump and his administration [...]
Scott Gottlieb

NCCS Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner

NCCS applauds the nomination of Dr. Scott Gottlieb for commissioner of the FDA. Dr. Gottlieb’s experience as a physician, a policymaker, and a patient uniquely qualifies him to lead the FDA at this important time. The agency confronts a rich pipeline of new products for cancer and other illnesses, and these products raise complicated scientific and clinical issues. FDA must also implement the provisions of the 21st Century Cures [...]
NCCS Starburst 250px

What Caught Our Eye: High-Risk Pools, “Trumpcare,” Childhood Cancer Survivors, Medicaid Spending, Trump’s FDA Deregulation

What Caught Our Eye (WCOE), March 3, 2017 What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy…
NCCS Starburst 250px

What Caught Our Eye: GOP ACA Talking Points Analysis, Right to Try Op-Ed, “Worry, Scan, Treat, Repeat”

Kaiser Health News’ Julie Rovner analyzes key Republican talking points on the ACA. One concern consumers have is high out-of-pocket costs. But, Rovner writes, “Republicans’ most popular proposals for replacing current individual insurance plans — cutting back on required benefits and giving more people access to tax-preferred health savings accounts — would likely increase [...]

Take Action

Link to: Survivorship Champions

Become a Survivorship Champion

Survivorship Champions is a program for all clinicians and researchers, both oncology and primary care, who are interested in improving survivorship care and primary care’s role in caring for cancer survivors.

Learn More and Join »
Link to: Cancer Policy and Advocacy Team (CPAT)

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Learn More and Join »
Link to: Survivor Stories

Share Your Story

NCCS represents the millions of Americans who share a common experience – living with, through and beyond a cancer diagnosis. By sharing your story of how you have been touched by cancer, you are supporting the national cancer survivorship movement.

Share Your Story »

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

Charity Navigator Four-Star Rating

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930 | Silver Spring, MD 20910
info@canceradvocacy.org | (877) NCCS-YES
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2024 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.